1. Think about the definition of stakeholders—any parties with a stake in the orga-
nization’s actions or performance. Who are the stakeholders in this situation?
How many can you list? On what basis would you rank them in importance?
2. What are the potential costs and benefits of such an investment?
3. If a safe and effective drug could be developed, the prospect of Merck’s recoup-
ing its investment was almost zero. Could Merck justify such an investment to
shareholders and the financial community? What criteria would be needed to
help them make such a decision?
4. If Merck decided not to conduct further research, how would it justify such a
decision to its scientists? How might the decision to develop the drug, or not to
develop the drug, affect employee loyalty?
5. How would the media treat a decision to develop the drug? Not to develop the
drug? How might either decision affect Merck’s reputation?
6. Think about the decision in terms of the CSR pyramid. Did Merck have an ethi-
cal obligation to proceed with development of the drug? Would it matter if the
drug had only a small chance to cure river blindness? Does it depend on how
close the company was to achieving a cure, or how sure they were that they could
achieve it? Or does this decision become a question of philanthropy only?
7. How does Merck’s value system fit into this decision?
8. If you were the senior executive of Merck, what would you do?
